Credit Agricole S A Anavex Life Sciences Corp. Transaction History
Credit Agricole S A
- $30.9 Billion
- Q1 2025
Shares
2 transactions
Others Institutions Holding AVXL
# of Institutions
207Shares Held
31MCall Options Held
1.3MPut Options Held
662K-
Black Rock Inc. New York, NY6.39MShares$53.5 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.9MShares$41 Million0.0% of portfolio
-
State Street Corp Boston, MA3.21MShares$26.9 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA1.96MShares$16.4 Million0.0% of portfolio
-
Nwam LLC Mercer Island, WA1MShares$8.37 Million0.77% of portfolio
About ANAVEX LIFE SCIENCES CORP.
- Ticker AVXL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 77,942,800
- Market Cap $652M
- Description
- Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system (CNS) diseases. Its lead drug candidate is ANAVEX 2-73, which is in Phase III clinical trial for the treatment of Alzheimer's disease; Phase III clinical trial to treat pediatric patien...